Synlogic, Inc. stock is traded on the Nasdaq Stock Market under the ticker symbol SYBX. Synlogic, Inc. is in the Biotechnology & Medical Research industry.
Synlogic, Inc. is a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases. The Company is focused on rare metabolic disorders, with its lead program, labafenogene marselecobac (SYNB1934), studied in Synpheny-3, a global, pivotal Phase 3 study for patients with phenylketonuria (PKU), and SYNB1353, a potential treatment for homocystinuria (HCU). The Company's early-stage pipeline includes product candidates for enteric hyperoxaluria, gout, and cystinuria, and has been fueled by a reproducible, proprietary approach that creates gastrointestinal (GI)-restricted, oral medicines with new enzymatic pathways designed to consume or produce specific biological targets. It designs, develops and manufactures these drug candidates, which are produced by applying genetic engineering to well-characterized probiotics. The Company’s preclinical work includes additional metabolic disease research.
Stock Ticker Symbol Lookup
Here you can look up another stock ticker symbol.
Stock Ticker Symbol GDTC
Here is another stock ticker symbol that we have information about!
Contact | Disclaimer | Copyright | Privacy